Thoracic transplantation has been a clinical option for patients with end-stage heart and lung disease for three decades. Heart, lung, and combined heart-lung transplantations are no longer experimental procedures; they are a standard part of the treatment algorithm for selected patients with end-stage heart and lung disease. This article summarizes the current status of heart, lung, and heart-lung transplantations and provides an insight into the future of this field.
|Original language||English (US)|
|Number of pages||6|
|Journal||Maryland medical journal (Baltimore, Md. : 1985)|
|State||Published - Jan 1 1998|